Home
About
Overview
Sharing Data
ORCID
Help
History (3)
ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready?
Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism.
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready?
ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready? JCO Precis Oncol. 2021 11; 5:767-770.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
authors with profiles
Ravi Salgia